| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 437.39 mm | 437.39 mm | 437.39 mm | 437.39 mm | 437.39 mm | 437.39 mm |
| Cash burn (monthly) | 32.24 mm | (no burn) | 32.37 mm | 28.66 mm | 28.11 mm | 24.36 mm |
| Cash used (since last report) | 66.97 mm | n/a | 67.25 mm | 59.54 mm | 58.40 mm | 50.62 mm |
| Cash remaining | 370.42 mm | n/a | 370.14 mm | 377.85 mm | 378.99 mm | 386.77 mm |
| Runway (months of cash) | 11.5 | n/a | 11.4 | 13.2 | 13.5 | 15.9 |
| 13F holders | Current |
|---|---|
| Total holders | 203 |
| Opened positions | 37 |
| Closed positions | 39 |
| Increased positions | 68 |
| Reduced positions | 61 |
| 13F shares | Current |
|---|---|
| Total value | 2.56 tn |
| Total shares | 128.76 mm |
| Total puts | 434.50 k |
| Total calls | 135.10 k |
| Total put/call ratio | 3.2 |
| Largest owners | Shares | Value |
|---|---|---|
| Atlas Venture Life Science Advisors | 8.02 mm | $188.94 bn |
| FMR | 8.00 mm | $188.41 bn |
| BlackRock | 7.95 mm | $187.29 bn |
| JHG Janus Henderson | 7.38 mm | $173.81 bn |
| Vanguard | 6.70 mm | $157.94 bn |
| Ra Capital Management | 6.38 mm | $150.34 bn |
| Capital Fund IV Cooperatief U.A. Forbion | 5.80 mm | $169.23 mm |
| Atlas Venture Fund XI | 5.71 mm | $166.85 mm |
| FCPM Iii Services B.V. | 5.46 mm | $128.70 bn |
| RTW Investments | 5.22 mm | $122.95 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 18 Feb 25 | Richard William Scalzo | Common Stock | Sell | Dispose S | No | Yes | 13.95 | 2,488 | 34.71 k | 124,590 |
| 18 Feb 25 | Oxana Beskrovnaya | Common Stock | Sell | Dispose S | No | Yes | 13.95 | 2,598 | 36.24 k | 199,087 |
| 27 Jan 25 | Rhodes Jason P | Common Stock | Grant | Acquire A | Yes | No | 13.5 | 1,111,111 | 15.00 mm | 1,958,427 |
| 11 Dec 24 | Richard William Scalzo | Common Stock | Sell | Dispose S | No | Yes | 28.12 | 1,455 | 40.91 k | 127,078 |
| 11 Dec 24 | Oxana Beskrovnaya | Common Stock | Sell | Dispose S | No | Yes | 28.12 | 2,334 | 65.63 k | 201,685 |
